Status:
UNKNOWN
TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners
Lead Sponsor:
Ced Service GmbH
Conditions:
Crohn Disease
Ulcerative Colitis
Eligibility:
All Genders
18-80 years
Brief Summary
By capturing possible or known risk factors, it will be possible to recognize connections between these risk factors and the disease, thus obtaining valuable insights into the cause of the disease. Th...
Detailed Description
In view of the high prevalence and currently unsatisfactory treatment status, there is a significant medical demand for more effective treatment options. These require greater knowledge about the cond...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Crohn's disease or Confirmed diagnosis of ulcerative colitis or Confirmed diagnosis of indeterminate colitis (IBDU)
- All types of treatment commensurate with the medical practice, independent of any study
- Age 18-80
- Ongoing or incipient targeted therapies with biologics and/or other targeted therapies (e.g. Janus kinase inhibitors)
- Sufficient ability to communicate in German language
- Patient must be able to recognize the nature, significance and scope of this registry and to act accordingly
- Computer/Tablet/mobile phone with internet access
Exclusion
- No declaration of consent is given
- Age \< 18 and \> 80
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
4400 Patients enrolled
Trial Details
Trial ID
NCT04031482
Start Date
October 1 2019
End Date
September 1 2023
Last Update
July 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.